Alzheimer’s drug donanemab helps most when taken at earliest disease stage, study finds
Sara Reardon
Topics & Concepts
DiseaseDrugAntibodyMedicineStage (stratigraphy)Amyloid (mycology)Drug discoveryPharmacologyImmunologyBioinformaticsBiologyInternal medicinePathologyPaleontologyAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesPharmacological Effects and Toxicity Studies